On Nov. 2, CNS
- Revenues and EPS came in well ahead of analyst estimates.
- Sales increased by 52.8% to $35.8 million, driven by strong performances from FiberChoice and Breathe Right nasal strips.
- EPS increased by 56.7% to $0.47 because of strong top-line growth, improved margins, and a decrease in diluted shares.
-
GlaxoSmithKline
(NYSE:GSK) is acquiring CNS for $37.50 per share.
(Figures in millions, except per-share data)
Income Statement Highlights
Avg. Est. |
Q2 2006 |
Q2 2005 |
Change |
|
---|---|---|---|---|
Sales |
$29,949 |
$35.8 |
$26.1 |
37.5% |
Net Profit |
-- |
$6.9 |
$4.5 |
52.8% |
EPS |
$0.28 |
$0.47 |
$0.30 |
56.7% |
Diluted Shares |
-- |
14.7 |
15.0 |
(2.3%) |
Get back to basics with a look at the income statement.
Margin Checkup
Q2 2006 |
Q2 2005 |
Change* |
|
---|---|---|---|
Gross Margin |
73.12% |
70.74% |
2.38 |
Operating Margin |
28.76% |
25.60% |
3.16 |
Net Margin |
19.32% |
17.38% |
1.94 |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
Assets |
Q2 2006 |
Q2 2005 |
Change |
---|---|---|---|
Cash + ST Invest. |
$60.5 |
$58.9 |
2.7% |
Accounts Rec. |
$21.3 |
$15.1 |
41.1% |
Inventory |
$6.3 |
$8.0 |
(21.3%) |
Liabilities |
Q2 2006 |
Q2 2005 |
Change |
---|---|---|---|
Accounts Payable |
No data |
$16.9 |
No data |
Long-Term Debt |
No data |
$0 |
No data |
Learn the ways of the balance sheet.
Cash Flow Highlights
YTD 2006 |
YTD 2005 |
Change |
|
---|---|---|---|
Cash From Ops. |
$9.9 |
$6.3 |
58.3% |
Capital Expenditures |
$0.4 |
$0.1 |
203.9% |
Free Cash Flow |
$9.5 |
$6.1 |
55.3 |
Find out why Fools always follow the money.
Related Companies:
-
Volcano
(NASDAQ:VOLC) -
Datascope
(NASDAQ:DSCP) -
Encore Medical
(NASDAQ:ENMC)
Related Foolishness:
- CNS Shareholders Can Breathe Easy
- Foolish Forecast: Soothsaying CNS
- Glaxo's Prescription for Sagging Sales
CNS is a Motley Fool Hidden Gems recommendation and GlaxoSmithKline is an Income Investor pick.Need new ideas for your money? See what other investors think of companies with CAPS.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.